Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control and Prevention
Open Access
Abstract
Coronavirus disease 2019 (COVID‐19) has rapidly spread worldwide, posing a serious public health problem.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2017R1C1B5076565)
This publication has 11 references indexed in Scilit:
- Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreakThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19Journal of Allergy and Clinical Immunology, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Risk factors for severity and mortality in adult COVID-19 inpatients in WuhanJournal of Allergy and Clinical Immunology, 2020
- Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)Allergy, 2020
- A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2Allergy, 2020
- Association of asthma and its genetic predisposition with the risk of severe COVID-19Journal of Allergy and Clinical Immunology, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January–May 2020Journal of Korean Medical Science, 2020